NCT04501952 Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting Status TERMINATED Phase PHASE3
NCT04495348 Explorations Into the Mechanism for INSTI-associated Weight Gain: a Focus on Energy Balance Status COMPLETED Phase N/A
NCT04483700 Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drug Therapy Status WITHDRAWN Phase PHASE3
NCT04483687 Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Have an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drug Therapy Status WITHDRAWN Phase PHASE3
NCT04468061 Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC Status RECRUITING Phase PHASE2
NCT04467684 Study Investigating the Safety, Tolerability, and PK, PD, of CB-0406 Status COMPLETED Phase PHASE1
NCT04454437 Study of Sacituzumab Govitecan in Chinese Patients With Metastatic Triple-negative Breast Cancer Who Received at Least Two Prior Treatments Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04453436 HIV Drug Resistance Among Individuals Failing Tenofovir/Lamivudine and Dolutegravir First Line Regimen in Brazil Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04448886 Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04431453 Study of Remdesivir in Participants Below 18 Years Old With COVID-19 Status COMPLETED Phase PHASE2/PHASE3
NCT04418037 DHFS for Medication Adherence Support During Hospital Admissions for Person Living With HIV Status COMPLETED Phase PHASE4
NCT04409262 A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia Status COMPLETED Phase PHASE3
NCT04382404 Treatment of Chronic Hepatitis C During Pregnancy With Sofosbuvir/Velpatasvir Status COMPLETED Phase PHASE1
NCT04381832 Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT04364035 Safety, Tolerability and Immunogenicity of MVA.HTI and ChAdOx1.HTI With Vesatolimod in HIV-1 Positive Patients Status COMPLETED Phase PHASE2
NCT04354818 Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA) Status UNKNOWN Phase N/A
NCT04328298 French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T) Status RECRUITING Phase N/A
NCT04323761 Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19) Status APPROVED_FOR_MARKETING Phase N/A